Prostate Cancer - Results from #27100

No association of type-2 diabetes risk variants and prostate cancer risk: The Multiethnic Cohort and PAGE - Abstract July 29, 2011

In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen - Abstract July 29, 2011

Prostatic disease and sexual dysfunction - Abstract July 29, 2011

Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients - Abstract July 29, 2011

Outcomes after prostate brachytherapy are even better than predicted - Abstract July 29, 2011

Rates and predictors of colorectal cancer screening by race among motivated men participating in a prostate cancer risk assessment program - Abstract July 29, 2011

Radiotherapy and short-term androgen deprivation for localized prostate cancer - Abstract July 29, 2011

Editor's Commentary - Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment July 29, 2011

Treatment of metastatic bone disease and treatment-induced osteoporosis in prostate cancer : Evolution of osteoprotective strategies - Abstract July 28, 2011

The association of diagnosis in the private or NHS sector on prostate cancer stage and treatment - Abstract July 28, 2011

Emerging treatment options for patients with castration-resistant prostate cancer - Abstract July 28, 2011

Biological significance of perineural invasion (PNI) in prostate cancer - Abstract July 28, 2011

ASTRO publishes white paper on IMRT safety July 28, 2011

Editor's Commentary - Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen July 28, 2011

Understanding preventive behaviors among mid-Western African-American men: A pilot qualitative study of prostate screening - Abstract July 27, 2011

Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer - Abstract July 27, 2011

Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: Competing-risks analysis of a large North American population-based cohort - Abstract July 27, 2011

Quality of life, behavioral problems, and marital adjustment in the first year after radical prostatectomy - Abstract July 27, 2011

Editor's Commentary - Abiraterone and increased survival in metastatic prostate cancer July 27, 2011

The future of uro-oncology : What needs to be done to secure its place in the field of urology? - Abstract July 26, 2011

Page 1356 of 1421